- Home
- MNMD vs BMBL Comparison
MNMD vs BMBL Comparison
Compare MNMD & BMBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNMD
- BMBL
- Stock Information
- Founded
- MNMD 2019
- BMBL 2014
- Country
- MNMD United States
- BMBL United States
- Employees
- MNMD N/A
- BMBL N/A
- Industry
- MNMD Pharmaceuticals and Biotechnology
- BMBL Computer Software: Prepackaged Software
- Sector
- MNMD Health Care
- BMBL Technology
- Exchange
- MNMD Nasdaq
- BMBL Nasdaq
- Market Cap
- MNMD 509.2M
- BMBL 446.5M
- IPO Year
- MNMD N/A
- BMBL 2021
- Fundamental
- Price
- MNMD $7.17
- BMBL $6.51
- Analyst Decision
- MNMD Strong Buy
- BMBL Hold
- Analyst Count
- MNMD 7
- BMBL 16
- Target Price
- MNMD $26.29
- BMBL $6.36
- AVG Volume (30 Days)
- MNMD 1.2M
- BMBL 3.2M
- Earning Date
- MNMD 08-12-2025
- BMBL 08-06-2025
- Dividend Yield
- MNMD N/A
- BMBL N/A
- EPS Growth
- MNMD N/A
- BMBL N/A
- EPS
- MNMD N/A
- BMBL N/A
- Revenue
- MNMD N/A
- BMBL $1,050,969,000.00
- Revenue This Year
- MNMD N/A
- BMBL N/A
- Revenue Next Year
- MNMD N/A
- BMBL N/A
- P/E Ratio
- MNMD N/A
- BMBL N/A
- Revenue Growth
- MNMD N/A
- BMBL N/A
- 52 Week Low
- MNMD $4.70
- BMBL $3.55
- 52 Week High
- MNMD $10.44
- BMBL $10.05
- Technical
- Relative Strength Index (RSI)
- MNMD 52.28
- BMBL 65.39
- Support Level
- MNMD $6.40
- BMBL $6.30
- Resistance Level
- MNMD $7.20
- BMBL $6.97
- Average True Range (ATR)
- MNMD 0.43
- BMBL 0.32
- MACD
- MNMD -0.03
- BMBL 0.13
- Stochastic Oscillator
- MNMD 76.03
- BMBL 78.88
About MNMD Mind Medicine (MindMed) Inc.
Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).
About BMBL Bumble Inc.
Bumble Inc is engaged in offering online dating services. The platform enables people to connect and build healthy and equitable relationships on their own terms. The company operates two apps, Bumble and Badoo, where users come every month to discover new people and connect. The company Operates in USA and also Internationally such as United Kingdom, Czech Republic, and others with maximum of revenue from Other Countries.